Scandinavian Cohort Study for Optimal Use of Portal Vein Embolization

Hepatic Neoplasm Clinical Trial

Official title: Scandinavian Cohort Study for Optimal Use of Portal Vein Embolization

Status Recruiting

Clinical Trial Summary

Several aspects on the use of portal vein embolization (PVE) are poorly studied and todays recommendations are based on low-grade evidence. In this Scandinavian multicenter cohort study we will study some of the controversial aspects on the use of PVE to try to provide clearer answers on its optimal use. Six tertiary university hospital hepatobiliary units in Sweden, Norway and Denmark participate and contribute with all PVE procedures performed at their units during the study period. We will then study several aspects PVE technique in relation to induced hypertrophy and surgical outcome.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Hepatic Neoplasm
• Liver Neoplasms

• NCT number: NCT04182386
• Study type: Observational
• Source: Karolinska University Hospital
• Contact: Ernesto Sparrelid, MD PhD
• Phone: +46-708-880787
• Email: ernesto.sparrelid@ki.se
• Status: Recruiting
• Start date: August 1, 2012
• Completion date: December 31, 2022